OTO Stock Chart & Stats
€4.04
--
Market closed
€4.04
--
Day’s Range― - ―
52-Week Range€2.66 - €7.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)630.00
Market Cap
€16.53M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,947,000
10 Day Avg. Volume300
30 Day Avg. Volume630
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OTO FAQ
What was Otofarma S.P.A.’s price range in the past 12 months?
Otofarma S.P.A. lowest stock price was €2.66 and its highest was €7.00 in the past 12 months.
What is Otofarma S.P.A.’s market cap?
Otofarma S.P.A.’s market cap is €16.53M.
When is Otofarma S.P.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Otofarma S.P.A.’s earnings last quarter?
Currently, no data Available
Is Otofarma S.P.A. overvalued?
According to Wall Street analysts Otofarma S.P.A.’s price is currently Overvalued.
Does Otofarma S.P.A. pay dividends?
Otofarma S.P.A. does not currently pay dividends.
What is Otofarma S.P.A.’s EPS estimate?
Otofarma S.P.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Otofarma S.P.A. have?
Otofarma S.P.A. has 5,947,000 shares outstanding.
What happened to Otofarma S.P.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Otofarma S.P.A.?
Currently, no hedge funds are holding shares in IT:OTO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Otofarma S.P.A.
Otofarma S.p.A. specializes in the manufacturing and distribution of bespoke hearing solutions. The company's comprehensive product range includes custom-fit, in-the-canal (ITC), and behind-the-ear (BTE) hearing aids, along with rechargeable options and various essential accessories. Founded in 2016, the firm's main office is located in Napoli, Italy, complemented by another branch in Milan. Effective August 5, 2025, Otofarma S.p.A. will function as a subsidiary of Bartolomucci Holding s.r.l.
Technical Analysis
Amplifon S.p.A.
―
―
Farmacosmo S.P.A.
―
Farmae SpA
―
I.M.D. International Medical Devices S.P.A.
―